This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

VIVUS Announces Scientific Presentations

MOUNTAIN VIEW, Calif., Nov. 12, 2013 (GLOBE NEWSWIRE) -- VIVUS,Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing Qsymia ® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today announced the following scientific presentations in connection with Obesity Week 2013:

Pre-Conference

Early Development Pharmacologic and Device Session for Up and Coming Obesity Treatments

Date/Time

Tuesday, November 12, 2013, 12:00 pm - 1:30 pm

Georgia World Congress Center, Room A404-A405

Conference

Obesity Week 2013: First Annual Obesity Week: A collaboration of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS)

November 11-16, 2013

Georgia World Congress Center, Atlanta, GA

Date/Time

Oral Presentation Date: November 14, 2013 from 3:00 PM to 4:30 PM

Session Location: Georgia World Congress Center, A404-A405

Abstract number: T-35-OR

Presentation Title

Depression and Weight Loss Over 2 Years in Obese and Overweight Subjects Receiving Phentermine and Topiramate Extended-Release

Authors: Patrick M. O'Neil, PhD a; Craig Peterson, MS b

Affiliations: aMedical University of South Carolina, Charleston, SC; bVIVUS, Inc., Mountain View, CA

Date/Time

Oral Presentation Date: Friday, November 15, 2013 from 4:30 to 4:45pm

Session Location: Georgia World Congress Center, A402-A403

Presentation Title

Evaluation of Phentermine and Topiramate vs. Phentermine/Topiramate Extended-Release in Obese Adults

Authors: Louis J. Aronne, MD a; Thomas A. Wadden, PhD b; Craig Peterson, MS c; David Winslow, MD d; Sarah Odeh, BS, CMPP c, and Kishore M. Gadde, MD e

Affiliations: aWeill Cornell Medical College, New York, NY; bPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA; cVIVUS, Inc., Mountain View, CA; dKentucky Research Group, Louisville, KY; eDuke University Medical Center, Durham, NC

Date/Time

Poster Presentation Date: November 14, 2013

  • Poster viewing: 10:00am - 3:30pm and 5:30pm - 7:00pm
  • Authors present posters: 5:30pm - 7:00pm

Session Location: Georgia World Congress Center, Exhibit Hall A

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,041.54 -190.48 -1.04%
S&P 500 2,104.20 -21.86 -1.03%
NASDAQ 5,032.7510 -56.6110 -1.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs